The briefing
A new study examines the policies and market factors that helped reduce the cost of diabetes medications in India. The analysis aims to extract lessons for other low- and middle-income countries seeking broader access to essential treatments.
Original headline
Study attempts to find out how India made expensive diabetes medicines affordable